[1] |
Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases[J]. Semin Hematol, 1995,32(1):45⁃59.
|
[2] |
Eder L, Bitterman H. Image in clinical medicine. Amyloid purpura[J]. N Engl J Med, 2007,356(23):2406. doi: 10.1056/NEJMicm061510.
|
[3] |
Mancuso G, Fanti PA, Berdondini RM. Nail changes as the only skin abnormality in myeloma⁃associated systemic amyloidosis[J]. Br J Dermatol, 1997,137(3):471⁃472. doi: 10.1111/j.1365⁃2133.1997.tb03764.x.
|
[4] |
Ahmad QM, Sultan SJ, Shah IH, et al. Systemic amyloidosis presenting as mucocutaneous bullous lesions[J]. Hematol Oncol Stem Cell Ther, 2009,2(3):418⁃421. doi: 10.1016/s1658⁃3876(09)50011⁃8.
|
[5] |
Gentry M, Pettenati M, Pang CS. Biclonal light chain gammopathy with aberrant CD33 expression in secondary plasma cell leukemia[J]. Int J Clin Exp Pathol, 2013,6(10):2224⁃2229.
|
[6] |
Jiwani S, Bornhost J, Alapat D. Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains[J]. Int J Clin Exp Pathol, 2015,8(7):8536⁃8544.
|
[7] |
Ahn YH, Rhee YY, Choi SC, et al. Localized Gastric Amyloidosis with Kappa and Lambda Light Chain Co⁃Expression[J]. Clin Endosc, 2018,51(3):285⁃288. doi: 10.5946/ce.2017.118.
|
[8] |
Grogg KL, Aubry MC, Vrana JA, et al. Nodular pulmonary amyloidosis is characterized by localized immunoglobulin deposition and is frequently associated with an indolent B⁃cell lymphoproliferative disorder[J]. Am J Surg Pathol, 2013,37(3):406⁃412. doi: 10.1097/PAS.0b013e318272fe19.
|